Additionally, the interaction of GAD65 antibodies with muscle tissue was confirmed using immunofluorescence techniques.<h4>Result</h4>Each patient exhibited symptoms akin to extraocular myasthenia gravis (MG), with two individuals reporting diplopia and two experiencing ptosis. The gene discussed is GAD2; the disease is ptosis.